Joint statement: NICE and SMC/HIS collaboration

25 November 2022 - NICE and SMC/HIS collaboration on the health technology appraisal of tixagevimab–cilgavimab (Evusheld) for preventing COVID-19. ...

Read more →

Scotland backs three new uses for MSD’s Keytruda

11 October 2022 - Scotland has become the first country in the UK to back NHS funding for the use ...

Read more →

SMC - October 2022 decisions

10 October 2022 - The SMC has today published advice on new medicines for six different conditions. ...

Read more →

Jazz Pharmaceuticals receives SMC approval for reimbursement of Sativex

14 September 2022 - Therapy is for the treatment of spasticity due to multiple sclerosis. ...

Read more →

Prostate cancer symptoms as new treatment given green light in Scotland

13 September 2022 - A new treatment for advanced prostate cancer has been approved for use in Scotland, giving medical ...

Read more →

Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland

13 September 2022 - The first and only body identical HRT for post-menopausal oestrogen deficiency, Bijuve, has been passed by ...

Read more →

The SMC recommends use of Hansa Biopharma's Idefirix (imlifidase) as desensitisation treatment for highly sensitised kidney transplant patients

12 September 2022 - The SMC decision follows the recent positive NICE recommendation for Idefirix in England, Wales and Northern ...

Read more →

Chiesi’s Trimbow recommended for use within NHS Scotland

18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland. ...

Read more →

SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy

10 August 2022 - Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the ...

Read more →

SMC - August 2022 decisions

8 August 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - July 2022 decisions

11 July 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - June 2022 decisions

13 June 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

First treatment option indicated for CKD in Scotland for 20 years

10 May 2022 - NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy ...

Read more →

SMC - May 2022 decisions

9 May 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - April 2022 decisions

12 April 2022 - Advice on three new medicines for use in conditions including a rare and fatal genetic condition affecting ...

Read more →